These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2878680)

  • 1. A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.
    Lammers JW; Müller ME; Folgering HT; van Herwaarden CL
    Br J Clin Pharmacol; 1986 Nov; 22(5):595-602. PubMed ID: 2878680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventilatory effects of atenolol and bevantolol in asthma.
    Lammers JW; Folgering HT; van Herwaarden CL
    Clin Pharmacol Ther; 1985 Oct; 38(4):428-33. PubMed ID: 4042527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of xamoterol (ICI 118,587) in asthmatic patients.
    Löfdahl CG; Svedmyr N
    Br J Clin Pharmacol; 1984 Oct; 18(4):597-601. PubMed ID: 6148960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
    Fitzgerald DE; Harry JD
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the relative safety of the beta-blockers ICI 141,292 and atenolol in patients with bronchial asthma.
    Groth S; Tønnesen P; Asted M; Dirksen H; Sørensen PG
    Eur J Clin Pharmacol; 1986; 30(6):653-8. PubMed ID: 3533563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventilatory and haemodynamic effects of terbutaline infusion during beta 1-selective blockade with metoprolol and acebutolol in asthmatic patients.
    Greefhorst AP; van Herwaarden CL
    Eur J Clin Pharmacol; 1982; 23(3):203-8. PubMed ID: 6756931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioselectivity of atenolol and metoprolol. A study in asthmatic patients.
    Löfdahl CG; Svedmyr N
    Eur J Respir Dis; 1981 Dec; 62(6):396-404. PubMed ID: 6751838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atenolol on ventilatory and cardiac function in asthma.
    Vilsvik JS; Schaanning J
    Br Med J; 1976 Aug; 2(6033):453-5. PubMed ID: 8188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteers.
    Sørensen EV; Jensen HK; Faergeman O
    Eur J Clin Pharmacol; 1991; 41(1):51-5. PubMed ID: 1685993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline.
    Löfdahl CG; Dahlöf C; Westergren G; Olofsson B; Svedmyr N
    Eur J Clin Pharmacol; 1988; 33 Suppl():S25-32. PubMed ID: 2836204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity of beta-adrenoceptor agonists and antagonists in asthmatics.
    Löfdahl CG
    Eur J Respir Dis Suppl; 1982; 120():1-53. PubMed ID: 6125404
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemodynamics in postural hypotension--effects of the beta-adrenoceptor partial agonist xamoterol, and pindolol.
    Mehlsen J; Trap-Jensen J
    Eur Heart J; 1990 Apr; 11 Suppl A():56-8. PubMed ID: 1971593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.
    Tangø M; Carlsen JE; Trap-Jensen J
    Eur J Clin Pharmacol; 1985; 29(2):155-8. PubMed ID: 2866963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventilatory effects of beta 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients.
    Lammers JW; Folgering HT; van Herwaarden CL
    Eur J Clin Pharmacol; 1984; 27(2):141-5. PubMed ID: 6149939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity of bevantolol hydrochloride, a beta 1-adrenoceptor antagonist, in asthmatic patients.
    Löfdahl CG; Svedmyr K; Svedmyr N
    Pharmacotherapy; 1984; 4(4):205-10. PubMed ID: 6148733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.
    Hashimoto T; Shiina A; Toyo-Oka T; Hosoda S; Kondo K
    Br J Clin Pharmacol; 1986 Mar; 21(3):259-65. PubMed ID: 2421751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of xamoterol a new beta-adrenoceptor partial agonist, in patients with angina pectoris.
    Barrios L; Geboers J; Piessens JH; de Geest H
    Eur J Clin Pharmacol; 1986; 29(6):667-71. PubMed ID: 2872055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.
    Tomlinson B; Cruickshank JM; Hayes Y; Renondin JC; Lui JB; Graham BR; Jones A; Lewis AD; Prichard BN
    Br J Clin Pharmacol; 1990 Nov; 30(5):665-72. PubMed ID: 1980200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dilevalol, a beta-adrenoceptor antagonist with intrinsic sympathetic activity in asthmatic patients.
    Hedner J; Ullman A; Lemne C; Svedmyr N
    Pulm Pharmacol; 1989; 2(3):155-9. PubMed ID: 2577692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.